TY - JOUR
T1 - Neuromodulation in headache and craniofacial neuralgia :
T2 - guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery Neuromodulación en cefaleas y neuralgias craneofaciales: Guía de la Sociedad Española de Neurología y de la Sociedad Española de Neurocirugía
AU - Belvís, Roberto
AU - Irimia, Pablo
AU - Seijo-Fernández, F.
AU - Paz, José
AU - García March, Guillermo
AU - Santos Lasaosa, Sonia
AU - Latorre, Germán
AU - González-Oria, Carmen
AU - Rodríguez, Rodrigo
AU - Pozo-Rosich, Patricia
AU - Lainez Andres, Jose Miguel
PY - 2021
Y1 - 2021
N2 - Introduction: Numerous invasive and non-invasive neuromodulation devices have been developed and applied to patients with headache and neuralgia in recent years. However, no updated review addresses their safety and efficacy, and no healthcare institution has issued specific recommendations on their use for these 2 conditions. Methods: Neurologists from the Spanish Society of Neurology's (SEN) Headache Study Group and neurosurgeons specialising in functional neurosurgery, selected by the Spanish Society of Neurosurgery (SENEC), performed a comprehensive review of articles on the MEDLINE database addressing the use of the technique in patients with headache and neuralgia. Results: We present an updated review and establish the first set of consensus recommendations of the SEN and SENC on the use of neuromodulation to treat headache and neuralgia, analysing the current levels of evidence on its effectiveness for each specific condition. Conclusions: Current evidence supports the indication of neuromodulation techniques for patients with refractory headache and neuralgia (especially migraine, cluster headache, and trigeminal neuralgia) selected by neurologists and headache specialists, after pharmacological treatment options are exhausted. Furthermore, we recommend that invasive neuromodulation be debated by multidisciplinary committees, and that the procedure be performed by teams of neurosurgeons specialising in functional neurosurgery, with acceptable rates of morbidity and mortality.
AB - Introduction: Numerous invasive and non-invasive neuromodulation devices have been developed and applied to patients with headache and neuralgia in recent years. However, no updated review addresses their safety and efficacy, and no healthcare institution has issued specific recommendations on their use for these 2 conditions. Methods: Neurologists from the Spanish Society of Neurology's (SEN) Headache Study Group and neurosurgeons specialising in functional neurosurgery, selected by the Spanish Society of Neurosurgery (SENEC), performed a comprehensive review of articles on the MEDLINE database addressing the use of the technique in patients with headache and neuralgia. Results: We present an updated review and establish the first set of consensus recommendations of the SEN and SENC on the use of neuromodulation to treat headache and neuralgia, analysing the current levels of evidence on its effectiveness for each specific condition. Conclusions: Current evidence supports the indication of neuromodulation techniques for patients with refractory headache and neuralgia (especially migraine, cluster headache, and trigeminal neuralgia) selected by neurologists and headache specialists, after pharmacological treatment options are exhausted. Furthermore, we recommend that invasive neuromodulation be debated by multidisciplinary committees, and that the procedure be performed by teams of neurosurgeons specialising in functional neurosurgery, with acceptable rates of morbidity and mortality.
KW - Neuromodulation
KW - Stimulation
KW - Headache
KW - Cluster headache
KW - Neuralgia
KW - Migraine
UR - https://www.scopus.com/pages/publications/85088799647
U2 - 10.1016/j.nrl.2020.04.022
DO - 10.1016/j.nrl.2020.04.022
M3 - Artículo
C2 - 32718873
SN - 0213-4853
VL - 36
SP - 61
EP - 79
JO - Neurologia
JF - Neurologia
IS - 1
ER -